Kegg medicus dgroup en
| DG01951 | |
| DG number | DG01951 |
| Classification | DGroup |
| Name | Catecholamine adrenergic receptor agonist TYPE Structure, Target, Class |
| Stem | - |
| Structural formula |  |
| Member | DG00211 Isoprenaline D08090 Isoprenaline (INN) D01390 Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN) D02066 Isoproterenol sulfate (USP); Isoprenaline sulfate (JAN) D02150 l-Isoprenaline hydrochloride (JP18) DG00212 Norepinephrine D00076 Noradrenaline (JP18); Norepinephrine (INN) D05206 Norepinephrine bitartrate (USP) D08284 Norepinephrine hydrochoride D09794 Norepinephrine hydrochloride (JAN) DG00216 Dobutamine D03879 Dobutamine (USAN/INN) D00632 Dobutamine hydrochloride (JP18/USP) D03880 Dobutamine lactobionate (USAN) D03881 Dobutamine tartrate (USAN) DG00222 Dopexamine D03891 Dopexamine (USAN/INN) D03892 Dopexamine hydrochloride (USAN) D02976 Arbutamine hydrochloride (USAN) DG00013 Epinephrine D00095 Epinephrine (USP/INN); Adrenaline (JP18) D00996 Epinephrine hydrochloride (JAN) D02149 Epinephrine bitartrate (JAN/USP) DG00248 Methyldopa (levorotatory) D08205 Methyldopa (INN) D00405 Methyldopa (USP); Methyldopa hydrate (JP18) D05730 Rimiterol hydrobromide (USAN) DG01047 Hexoprenaline D08039 Hexoprenaline (INN) D02396 Hexoprenaline sulfate (USAN) DG01234 Isoetharine D04625 Isoetharine (USP); Isoetarine (INN) D02093 Isoetharine hydrochloride (USP) D04626 Isoetharine mesylate (USP) DG01056 Bitolterol D07534 Bitolterol (INN) D00684 Bitolterol mesylate (USAN); Bitolterol mesilate (JAN) DG00016 Adrenalone D02774 Adrenalone (USAN/INN) D07560 Adrenalone hydrochloride DG01129 Dipivefrine D02349 Dipivefrin (USAN); Dipivefrine (INN) D01017 Dipivefrin hydrochloride (USP); Dipivefrine hydrochloride (JAN) D02614 Denopamine (JAN/INN) DG01444 Racepinephrine D05688 Racepinephrine (USP/INN) D05689 Racepinephrine hydrochloride (USP) D02388 Levonordefrin (USP); Corbadrine (INN) D03587 Colterol mesylate (USAN) D04708 Levdobutamine lactobionate (USAN) |
| Upper group | Cardiovascular agent |
| Remark | - |
| Comment | - |